RGT 1.92% 26.5¢ argent biopharma limited

Ann: Additional Information on Ground-breaking Research, page-12

  1. 5,264 Posts.
    lightbulb Created with Sketch. 1642
    WRONG. NOT ready to use on humans. READ the announcement carefully. 2nd last bullet point says; "will proceed", i.e. phase 2 in-vitro YET to be done. Last bullet point says, based on that (AFTER YET TO BE DINE 2nd phase) the company will DESIGN test on humans. (a) in-vitro is YET to be done, (b) IF, yeah, IF, that is positive then will start design a test, I.e. not even then will start test on humans. Have you heard of ethics approvals ... to start with? Do you know anything about clinical trials?

    It is BS (use of "MASSIVE" is a dead give away) posts like this, and persistant ambiguity in announcements that has ABSOLUTELY HAMMERED the SP long term by creating a YoYo.

    Dear management, I thank you yet again on behalf of day traders and I thank you NOT on behalf of long term holders. This could have been a simple good step BUT your announcement today stuffed it up! Agan, than you NOT.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.